Patents by Inventor David Kopecky

David Kopecky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11959368
    Abstract: A system for protecting an Electrical Submersible Pump (ESP) string from gas slugs in a downhole well environment. The system comprises an intake tube having a first and second end and one of a packer having a bypass channel and an inverted shroud coupled to the intake tube and the ESP string. The intake tube is independent of a pump and a motor of the ESP string. The system can comprise a bypass tube for channeling the gas slug downstream of the pump. The bypass tube is integrated with the packer. The inverted shroud is coupled with the first end of the intake tube and a section of production tubing downstream from the pump and the motor. The inverted shroud forms a bypass path channel within a casing annulus.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: April 16, 2024
    Assignee: HALLIBURTON ENERGY SERVICES, INC
    Inventors: Donn J. Brown, David C. Beck, Trevor A. Kopecky
  • Publication number: 20070155777
    Abstract: Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic, infectious and cell proliferative diseases or conditions are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism, infection and cell proliferation. The subject compounds contain a fused heterobicyclic ring.
    Type: Application
    Filed: February 21, 2007
    Publication date: July 5, 2007
    Applicants: Tularik Inc.
    Inventors: Simon Burkitt, Mario Cardozo, Timothy Cushing, Michael DeGraffeneid, Christopher Farthing, Xiaolin Hao, Juan Jaen, Xian Jiao, David Kopecky, Marc Labelle, Sarah Lively, Dustin McMinn, Sven Rasmussen, Youngsook Shin, Andrew Smith, Marie-Louise Smith
  • Publication number: 20070072851
    Abstract: The present invention relates to compounds of Formula I or a stereomer, a tautomer, a solvate, a pharmaceutically acceptable salt, or a prodrug thereof, pharmaceutical formulations containing the compounds, methods of treatments using the compounds, for example, protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders and methods of preparing medicaments comprising the compounds.
    Type: Application
    Filed: August 18, 2006
    Publication date: March 29, 2007
    Applicant: Amgen Inc.
    Inventors: John Buchanan, William Buckner, Mario Cardozo, Erin DiMauro, Jiasheng Fu, Xiaolin Hao, Xian Jiao, Frank Kayser, David Kopecky, Craig Masse, Susan Tomlinson, Ryan White, Xiaotian Zhu
  • Publication number: 20060270718
    Abstract: Heterocyclic arylsulfonamidobenzylic compounds are provided which are useful in treating lipid disorders, metabolic disorders and cell-proliferative diseases.
    Type: Application
    Filed: August 8, 2006
    Publication date: November 30, 2006
    Inventors: Xian Jiao, Frank Kayser, David Kopecky, Sharon McKendry, Derek Piper, Andrew Shiau
  • Publication number: 20060264424
    Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment or prevention of lipid disorders, metabolic disorders and cell-proliferative diseases. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in cholesterol metabolism. The subject compounds are particularly useful in the treatment of obesity, diabetes, hypercholesterolemia, atherosclerosis and hypolipoproteinemia.
    Type: Application
    Filed: August 11, 2004
    Publication date: November 23, 2006
    Applicant: Tularik Inc
    Inventors: Martin Harrison, Xian Jiao, Stuart Jones, Frank Kayser, David Kopecky
  • Publication number: 20060040965
    Abstract: Compounds that modulate the action of ACK1 and LCK, and related compositions methods for treating ACK1- and LCK-mediated diseases are described. In one aspect, the compounds have the general structure: where the values of the substituents are provided herein.
    Type: Application
    Filed: June 29, 2005
    Publication date: February 23, 2006
    Inventors: Christopher Farthing, Paul Faulder, Alexander Frenkel, Martin Harrison, Xianyun Jiao, Frank Kayser, David Kopecky, Jinqian Liu, Sarah Lively, Rajiv Sharma, Stephen Shuttleworth